Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03911024
Other study ID # HSC-SN-18-0501
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 20, 2019
Est. completion date August 1, 2019

Study information

Verified date October 2019
Source The University of Texas Health Science Center, Houston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is develop and pilot test a personalized HIV intervention with youth experiencing homelessness by creating and field testing prevention messages that address real-time predictors (e.g., sexual urge, use to use drugs, and substance use) of HIV risk behaviors,to evaluate the feasibility and acceptability of the intervention and to evaluate the intervention outcome effects on HIV risk behaviors (e.g., condomless sex, number of sexual partners, pre-exposure prophylaxis(PrEP) awareness, substance use during sex,Intravenous(IV)drug use)


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date August 1, 2019
Est. primary completion date August 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria:

- English speaking

- HIV high risk: IV drug user or sexually active youth (sex in the past 3 months) who reports at least one of the following: condomless sex, concurrent sexual partners within 2 weeks,sex with a partner of unknown HIV status, or a bacterial STI in the last 6 months.

- Homelessness: staying on the streets or in a place not meant for human habitation, a shelter,hotel/motel, or some place they cannot stay for more than 30 days

Exclusion Criteria:

- Below 6th grade reading level:determined by the Rapid Estimate of Adult Literacy in Medicine Short Form (REALM)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
HIV
At the completion of each EMA, participants in the intervention group (n=50) will receive messages that address:1) unsafe sexual behaviors, 2) alcohol/drug use, 3) PrEP interest, and 4) HIV testing. In addition, participants will have access to a button in the app that will link them to resources when/if they are the victim of sexual assault. Finally, intervention arm youth will be asked to set a behavioral goal related to HIV prevention during this session. Those goals will include increasing condom use, PrEP use, non-occupational post-exposure prophylaxis (nPEP) use, reducing number of sexual partners, not having sex with using drugs or drinking alcohol, avoiding IV drug use, getting testing for HIV, and testing and treating sexually transmitted infections (STIs) as needed
General health
Participants in the attention control condition (n=50) will answer the same EMA items as the Intervention group. However, the intervention messages will contain content related to nutrition, physical activity, sleep hygiene, and tobacco use. Finally, control arm youth will be asked to set a behavioral goal related to general health during this session.Those goals will include getting 7+ hours of sleep, eating >= 5 servings of fruits or vegetables, not using tobacco products, exercising at least 60 minutes.

Locations

Country Name City State
United States The University of Texas Health Science Center at Houston Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility as assessed by number recruited Number recruited is number of eligible youth minus number who refuse to participate. baseline
Primary Feasibility as assessed by number of participants who complete the study 6 weeks
Primary Feasibility as assessed by number of staff hours required 6 weeks
Primary Feasibility as assessed by number of participants who damage or lose phones 6 weeks
Primary Acceptability as assessed by score on the System Usability Scale (SUS) The System Usability Scale (SUS) consists of 10 items on a 5-point (0-4) Likert scale and is designed to assess acceptability of a product. Overall score ranges from 0 to 100, with higher scores indicating greater acceptability. 6 weeks
Primary Acceptability as assessed by score on the Mobile App Rating Scale (MARS) The Mobile App Rating Scale (MARS) consists of 23 items on a 5-point (1-5) scale is designed to score apps on the criteria of engagement, functionality, aesthetics, and information quality (sub-scales). Total score is determined by calculating the mean of each sub-scale and an overall mean score. High mean scores indicate a higher quality app. 6 weeks
Primary Number of participants who complete greater than 80% of the Ecological Momentary Assessments (EMAs) 6 weeks
Primary Number of participants who read greater than 80% of Just-In-Time Adaptive Intervention (JITAI) messages 6 weeks
Primary Effect on HIV risk behaviors as assessed by number of participants who use condoms 6 weeks
Primary Effect on HIV risk as assessed by number who use substances before sex 6 weeks
Primary Effect on HIV risk as assessed by number of participants who have pre-exposure prophylaxis (PrEP) interest 6 weeks
Primary Effect on HIV risk as assessed by number of participants who undergo HIV or sexually transmitted infection (STI) testing 6 weeks
Primary Effect on HIV risk as assessed by number of sexual partners 6 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03910218 - Come As You Are - Assessing the Efficacy of a Nurse Case Management HIV Prevention and Care Intervention Among Homeless Youth N/A
Recruiting NCT06192316 - Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior N/A
Not yet recruiting NCT05349877 - Efficacy of a Brief Intervention to Improve Sexual and Gender Minorities' Mental Health: Randomized Controlled Trial. N/A